Asia-Pacific breast cancer market to reach US$ 3.4 bn by 2021: GBI Research

Asia-Pacific breast cancer market to reach US$ 3.4 bn by 2021: GBI Research

Deekshita Allavarapu, analyst for GBI Research, explains “It is anticipated that popular drugs, such as Afinitor and Herceptin, will be used in conjunction with several promising breast cancer pipeline treatments. These include abemaciclib, buparlisib

(Visited 1 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.